Correlation Between CRISPR Therapeutics and 3M

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and 3M at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and 3M into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and 3M Company, you can compare the effects of market volatilities on CRISPR Therapeutics and 3M and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of 3M. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and 3M.

Diversification Opportunities for CRISPR Therapeutics and 3M

  Correlation Coefficient

Very good diversification

The 3 months correlation between CRISPR and 3M is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and 3M Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 3M Company and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with 3M. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 3M Company has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and 3M go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and 3M

Given the investment horizon of 90 days CRISPR Therapeutics is expected to generate 14.24 times less return on investment than 3M. In addition to that, CRISPR Therapeutics is 2.19 times more volatile than 3M Company. It trades about 0.01 of its total potential returns per unit of risk. 3M Company is currently generating about 0.41 per unit of volatility. If you would invest  13,020  in 3M Company on May 13, 2022 and sell it today you would earn a total of  1,918  from holding 3M Company or generate 14.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
ValuesDaily Returns

CRISPR Therapeutics AG  vs.  3M Company

 Performance (%) 
CRISPR Therapeutics 
CRISPR Performance
12 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, CRISPR Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

CRISPR Price Channel

3M Company 
3M Performance
1 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in 3M Company are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively steady primary indicators, 3M is not utilizing all of its potentials. The latest stock price chaos, may contribute to medium-term losses for the stakeholders.

3M Price Channel

CRISPR Therapeutics and 3M Volatility Contrast

   Predicted Return Density   

Pair Trading with CRISPR Therapeutics and 3M

The main advantage of trading using opposite CRISPR Therapeutics and 3M positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, 3M can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 3M will offset losses from the drop in 3M's long position.

CRISPR Therapeutics AG

Pair trading matchups for CRISPR Therapeutics

The idea behind CRISPR Therapeutics AG and 3M Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

3M Company

Pair trading matchups for 3M

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bond Directory
Find actively traded corporate debentures issued by US companies
Fundamental Analysis
View fundamental data based on most recent published financial statements
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance